SWAIN, S. 2-hour 75 gm OGTT for screening and Rescreening at 32-34 weeks for diagnosing gestational diabetes-evaluation of maternal and neonatal outcomes. International Journal of Reproduction, Contraception, Obstetrics and Gynecology, [S. l.], v. 6, n. 7, p. 2926–2932, 2017. DOI: 10.18203/2320-1770.ijrcog20172909. Disponível em: https://www.ijrcog.org/index.php/ijrcog/article/view/2808. Acesso em: 7 oct. 2025.